SMTL ID : 8tj6.4 (3 other biounits)

CRYSTAL STRUCTURE OF THE A/Beijing/353/1989(H3N2) INFLUENZA VIRUS HEMAGGLUTININ WITH HUMAN RECEPTOR ANALOG 6'-SLN

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

hetero-3-3-mer

Ligands

6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: S.39, N.279, V.291, N.292 Chain B: E.69 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 4 residues within 4Å: Chain A: N.32, T.34, T.312 Chain B: L.52 No protein-ligand interaction detected (PLIP) NAG-NAG.9: 5 residues within 4Å: Chain C: S.39, N.279, V.291, N.292 Chain D: E.69 No protein-ligand interaction detected (PLIP) NAG-NAG.11: 4 residues within 4Å: Chain C: N.32, T.34, T.312 Chain D: L.52 No protein-ligand interaction detected (PLIP) NAG-NAG.17: 5 residues within 4Å: Chain E: S.39, N.279, V.291, N.292 Chain F: E.69 No protein-ligand interaction detected (PLIP) NAG-NAG.19: 4 residues within 4Å: Chain E: N.32, T.34, T.312 Chain F: L.52 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.2: 6 residues within 4Å: Chain A: N.159, T.161 Chain E: S.213, R.214, P.215, W.216 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:W.216 NAG-NAG-BMA-MAN-MAN.10: 6 residues within 4Å: Chain A: S.213, R.214, P.215, W.216 Chain C: N.159, T.161 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:W.216 NAG-NAG-BMA-MAN-MAN.18: 6 residues within 4Å: Chain C: S.213, R.214, P.215, W.216 Chain E: N.159, T.161 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:W.216

3 x NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-GAL-SIA.4: 12 residues within 4Å: Chain A: Y.92, G.128, E.129, S.130, Y.131, K.139, W.147, H.177, E.184, L.188, L.220, S.222 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:G.219, A:Y.92, A:E.129, A:Y.131, A:K.139, A:H.177, A:E.184, A:S.222 NAG-GAL-SIA.12: 12 residues within 4Å: Chain C: Y.92, G.128, E.129, S.130, Y.131, K.139, W.147, H.177, E.184, L.188, L.220, S.222 7 PLIP interactions: 7 interactions with chain C Hydrogen bonds: C:G.219, C:Y.92, C:E.129, C:Y.131, C:K.139, C:H.177, C:E.184, C:S.222 NAG-GAL-SIA.20: 12 residues within 4Å: Chain E: Y.92, G.128, E.129, S.130, Y.131, K.139, W.147, H.177, E.184, L.188, L.220, S.222 7 PLIP interactions: 7 interactions with chain E Hydrogen bonds: E:G.219, E:Y.92, E:E.129, E:Y.131, E:K.139, E:H.177, E:E.184, E:S.222

12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.5: 3 residues within 4Å: Chain A: K.56, N.57, Y.88 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:K.56 Hydrogen bonds: A:N.57 NAG.6: 2 residues within 4Å: Chain A: N.120, T.122 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.122 NAG.7: 2 residues within 4Å: Chain A: N.16, N.32 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.16 NAG.8: 3 residues within 4Å: Chain B: G.150, R.153, N.154 2 PLIP interactions: 2 interactions with chain B Hydrophobic interactions: B:R.153 Hydrogen bonds: B:R.153 NAG.13: 3 residues within 4Å: Chain C: K.56, N.57, Y.88 2 PLIP interactions: 2 interactions with chain C Hydrophobic interactions: C:K.56 Hydrogen bonds: C:N.57 NAG.14: 2 residues within 4Å: Chain C: N.120, T.122 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:T.122 NAG.15: 2 residues within 4Å: Chain C: N.16, N.32 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:N.16 NAG.16: 3 residues within 4Å: Chain D: G.150, R.153, N.154 2 PLIP interactions: 2 interactions with chain D Hydrophobic interactions: D:R.153 Hydrogen bonds: D:R.153 NAG.21: 3 residues within 4Å: Chain E: K.56, N.57, Y.88 2 PLIP interactions: 2 interactions with chain E Hydrophobic interactions: E:K.56 Hydrogen bonds: E:N.57 NAG.22: 2 residues within 4Å: Chain E: N.120, T.122 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:T.122 NAG.23: 2 residues within 4Å: Chain E: N.16, N.32 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:N.16 NAG.24: 3 residues within 4Å: Chain F: G.150, R.153, N.154 2 PLIP interactions: 2 interactions with chain F Hydrophobic interactions: F:R.153 Hydrogen bonds: F:R.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Thompson, A.J. et al., Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site. Cell Host Microbe (2024)

Release Date

2024-02-14

Peptides

Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
G

C
G

E
G

B
H

D
H

F
H

Hemagglutinin HA1 chain

Hemagglutinin HA2 chain

Related Entries With Identical Sequence